Oncobiologics-Ipca JV will replicate US biosimilars plant in India
Oncobiologics will replicate its US biomanufacturing facility in India as part of a new biosimilars-focussed deal penned with drugmaker Ipca.
Archives for June 2, 2014
GSK to develop Adaptimmune’s melanoma and ovarian cancer biologic
GSK will develop and commercialise Adaptimmune’s T-cell receptor (TCR) cancer therapies in a deal that could yield more than $350m (€257m) for the Oxford, UK biopharma firm.
Another Soliris recall as Alexion evaluates its manufacturing network
Alexion has recalled another nine lots of Soliris after finding "visible particles" in vials of the $600,000-a-year drug for the third time in 10 months.